Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids)
Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169)
05/2000
05/10/2000EP0998455A1 Dihomo-seco-cholestanes with two unsaturated bones in the side chain
05/10/2000EP0998454A2 Metalloproteinase inhibitors
05/10/2000EP0998306A1 Liposomal compositions for the delivery of nucleic acid catalysts
05/10/2000EP0998300A1 Methods and compositions for modulating responsiveness to corticosteroids
05/10/2000EP0998288A1 Compositions containing capsaicin or capsaicin analogues and a local anesthetic
05/10/2000EP0998283A1 Calcilytic compounds
05/10/2000EP0998282A1 Sulfonamides as cell adhesion inhibitors
05/10/2000EP0998275A1 INHIBITION OF NUCLEAR TRANSCRIPTION FACTOR NF-kappaB BY CAFFEIC ACID PHENETHYL ESTER (CAPE), DERIVATIVES OF CAPE, CAPSAICIN (8-METHYL-N-VANILLYL-6-NONENAMIDE) AND RESINIFERATOXIN
05/10/2000EP0800503B1 Novel trienoic retinoid compounds and methods
05/10/2000EP0743939B1 Aralkoxy and aralkylthio substituted azacyclic compounds as tachykinin antagonists
05/10/2000CN1252811A Gamma-1 and gamma-3 anti-human CD23 monoclonal antibodies and use as the rapentics
05/10/2000CN1252809A Modified TNF alpha molecules, DNA encoding such modified TNF alpha molecules and vaccines comprising such modified TNF alpha molecules and DNA
05/10/2000CN1252799A N-heterocyclic derivatives as NOS inhibitor
05/10/2000CN1252790A N-hydroxy-2-(alkyl, aryl or heteroaryl sulfanyl, sulfinyl or sulfonyl)-3-substituted alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors
05/10/2000CN1252725A Analgesic combination
05/10/2000CN1252721A Pharmaceutical composition
05/10/2000CN1252713A N-hydroxy-2-(alkyl, aryl or heteroaryl sulfanyl, sulfinyl or sulfonyl)-3-substituted alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors
05/10/2000CN1252705A Sustained analgesia achieved with buprenorphine
05/10/2000CN1252299A Antiphlogistic cough-relieving medicine
05/10/2000CN1052231C 2-oxo-5-oxazolidone methyl compound their preparing method and medicinal composition containing them
05/10/2000CN1052227C Oxazolidone used as adhesive receptor antagenists, its preparing method and medicinal composition containing them
05/10/2000CN1052155C Process for preparing pharmaceutical composition containing new steriod compounds
05/09/2000US6060588 Bap-1 proteins
05/09/2000US6060504 Administering heat stable crystal form of kappa-opiate agonist asimadoline hydrochloride to treat inflammatory gastrointestinal disorders and simultaneously relieve pain with side effect reduction
05/09/2000US6060494 Crystal form of N-(4-trifluoromethylphenyl)-5-methylisoxazole-4-carboxamide
05/09/2000US6060479 Quinazoline-4-one AMPA antagonists
05/09/2000US6060469 Spiro-piperidine derivatives and their use as tachykinin antagonists
05/09/2000US6060468 N-substituted azaheterocyclic compounds
05/09/2000US6060453 Immunomodulatory, anti-inflammatory, and anti-proliferative compounds: 5,6-dideoxy, 5-amino derivatives of idose and 6-deoxy, 6-amino derivatives of glucose
05/09/2000US6060250 Human transferases
05/09/2000US6060239 Cellubrevin homologs
05/09/2000US6060085 Dissolved drug that has the capacity to permeate the stratum corneum layer of the epidermis and become available systemically, and a drug in a microparticulate state that does not readily cross the stratum corneum
05/09/2000US6060061 Method for preventing or treating disorders involving an inflammatory process
05/09/2000CA2153584C Cytokine restraining agents
05/09/2000CA2129679C Imidazolyl or imidazoylalkyl substituted with a four or five membered nitrogen containing heterocyclic ring
05/09/2000CA2112239C Enantiomeric hydroxylated xanthine compounds
05/04/2000WO2000024911A2 Human phospholipases
05/04/2000WO2000024910A1 Process of purification of low density lipoprotein associated phospholipase a2 using immobilized metal affinity chromatography
05/04/2000WO2000024907A2 Library of novel "unnatural" natural products
05/04/2000WO2000024886A1 Prv-1 gene and the use thereof
05/04/2000WO2000024782A2 Modified peptides, comprising an fc domain, as therapeutic agents
05/04/2000WO2000024744A1 Bicyclic nitrogen heterocycles
05/04/2000WO2000024742A1 Pyrazolopyridine as adenosine antagonists
05/04/2000WO2000024719A1 Prostaglandin endoperoxide h synthase biosynthesis inhibitors
05/04/2000WO2000024710A1 N-(2-aryl-propionyl)-sulfonamides and pharmaceutical preparations containing them
05/04/2000WO2000024707A1 Substituted phenyl derivatives, their preparation and use
05/04/2000WO2000024427A1 Remedies for rheumatism containing fadd gene as the active ingredient
05/04/2000WO2000024393A1 Combination product comprising an e-type prostaglandin ligand and a cox-2 selective inhibitor and methods of use
05/04/2000WO2000024386A1 Method of making pressure sensitive adhesive matrix patches containing hydrophilic salts of drugs
05/04/2000WO2000024375A1 Preservative system for topically administrable pharmaceutical compositions containing a fatty acid/amino acid soap
05/04/2000WO2000024373A1 O/w emulsion comprising an hydroxylated oil
05/04/2000WO2000006730A3 Human cytoskeletal proteins
05/04/2000WO2000006254A3 Non-imidazole alkylamines as histamine h3-receptor ligands and their therapeutic applications
05/04/2000WO2000006187A3 Modulation of apoptosis
05/04/2000WO2000006085A3 Compounds and methods
05/04/2000WO2000004868A3 Libraries of polyhydroxamates and their analogs
05/04/2000WO1999067283A8 Two-kinase domain mitogen- and stress-activated protein kinases and uses thereof
05/04/2000WO1999043672A9 Inhibitors of phospholipase a2
05/04/2000WO1998025595A3 Aqueous drink composition comprising ibuprofen
05/04/2000DE19850131A1 Chromenon- und Chromanonderivate Chromenon- and chromanone
05/04/2000CA2349211A1 Prv-1 gene and the use thereof
05/04/2000CA2348833A1 Human phospholipases
05/04/2000CA2347982A1 Prostaglandin endoperoxide h synthase biosynthesis inhibitors
05/04/2000CA2347365A1 Combination product comprising an e-type prostaglandin ligand and a cox-2 selective inhibitor and methods of use
05/04/2000CA2347128A1 Library of novel "unnatural" natural products
05/04/2000CA2347032A1 O/w emulsion comprising an hydroxylated oil
05/04/2000CA2343100A1 Method of making pressure sensitive adhesive matrix patches containing hydrophilic salts of drugs
05/04/2000CA2342626A1 Substituted phenyl derivatives, their preparation and use
05/04/2000CA2340225A1 Preservative system for topically administrable pharmaceutical compositions containing a fatty acid/amino acid soap
05/03/2000EP0997464A1 1,3,8-Triazaspiro[4,5] decanone compounds as orl1-receptor agonists
05/03/2000EP0997463A1 Naphthyridine derivatives
05/03/2000EP0996731A2 Retroviral nucleic material and nucleotide fragments, in particular associated with multiple sclerosis and/or rheumatoid arthritis, for diagnostic, prophylactic and therapeutic uses
05/03/2000EP0996726A1 T-cell membrane protein (tirc7), peptides and antibodies derived therefrom and uses thereof
05/03/2000EP0996630A2 Irs-p53h, human insulin receptor tyrosine kinase substrate
05/03/2000EP0996617A1 Novel compounds
05/03/2000EP0996468A1 Conjugates of galactose-binding lectins and clostridial neurotoxins as analgesics
05/03/2000EP0996465A1 Compositions and articles for reducing the effects of inflammation
05/03/2000EP0996446A1 Novel substituted imidazole compounds
05/03/2000EP0996437A1 Semisolid pharmaceutical formulation containing dexketoprofen trometamol
05/03/2000EP0996433A1 Methods for treatment of conditions associated with lactosylceramide
05/03/2000EP0743940B1 New compounds with analgesic and local anaesthetic effect
05/03/2000CN1252071A Substituted (1,3-bis(cyclohexylmethyl)-1,2,3,6-tetrahydro-2,6-dioxo-9H-purin-8-yl) phenyl derivatives, their preparation and use in treatment of inflammatory conditions and immune disorders
05/03/2000CN1252069A 5,6,7-trisubstituted-4-aminopyrido [2,3-d] pyrimidine compounds
05/03/2000CN1252064A Bicyclic amino acids
05/03/2000CN1251997A Treatment of chronic inflammatory diseases with CM 101/GBS toxin
05/03/2000CN1052004C Heterocyclic compounds, their production and use
05/03/2000CN1052003C Prodrugs of antiinflammatory 3-acyl-2-oxidole-1-carboxamides
05/03/2000CN1052002C 4-aryl-4-hydroxy-tetrahydropyrans and 3-aryl-3-hydroxy-tetrahydrofurans, preparation thereof and medicinal composition comprising them
05/03/2000CN1051998C Isoquinolines preparation thereof and its medicinal compositions
05/02/2000US6057457 Pyrrolopyrrolone derivatives as inhibitors of neutrophil elastase
05/02/2000US6057454 1-oxo-1H-inden-2-yl-1H-imidazole-2-carboxylic acid intermediates
05/02/2000US6057445 Formation of carbon nitrogen bond, cyclization and halogenation
05/02/2000US6057440 Process for preparing bis-indoly macrocycles
05/02/2000US6057435 Nucleic acid coding for polypeptide which binds to receptor tyrosine kinase containing immunoglobulin-like and epidermal growth factor homology domains expressed in vascular endothelial cells; diagnosis/imaging; angiogenesis inhibition
05/02/2000US6057426 Nucleotide and amino acid sequences of polypeptide capable of inducing leukocyte migration and/or activating leukocytes in a dose-dependent manner; diagnosis/screening/therapy; for increasing cell layer permeability for drug circulation
05/02/2000US6057369 Use in the treatment of disease states associated with proteins that mediate cellular activity which are capable of being modulated by inhibiting a matrix metalloproteinase (mmp), tumor necrosis factor (tnf) or cyclic amp
05/02/2000US6057362 Protease inhibitors
05/02/2000US6057351 Compounds of the 3-aryl 2,4 dioxo oxazolidine family and use thereof in cosmetic and pharmaceuticals
05/02/2000US6057347 Comprising nonsteroidal antiinflammatory drug and compound that donates, transfers, or releases nitric oxide, elevates endogenous synthesis levels of nitric oxide, or is substrate for nitric oxide synthase
05/02/2000US6057329 Inhibitors of the protein tyrosine kinases and are of use in the prophylaxis and treatment of immune diseases, hyperproliferative disorders and other diseases
1 ... 1058 1059 1060 1061 1062 1063 1064 1065 1066 1067 1068 1069 1070 1071 1072 1073 1074 1075 1076 1077 1078 ... 1272